IC
Posted:
March 02, 2026
Location:
Dublin, Ireland, Ireland
Job Description
Senior Director, Finance - Group Accounting & Reporting - Dublin UK Hybrid or Home
ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us on our mission to shape the future of clinical development.
**The Role:**
ICON plc, a leading global provider of outsourced development and commercialisation services to the pharmaceutical, biotechnology, and medical device industries, is seeking a Senior Director, Group Accounting & Reporting to join our world-class finance team.
In this highly visible role, you will act as a key advisor on ICON’s global accounting and reporting, ensuring compliance with US GAAP and IFRS standards, and providing critical guidance that shapes our financial strategy as a NASDAQ-listed, Irish-headquartered organisation. With over 1,200 professionals a...
ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us on our mission to shape the future of clinical development.
**The Role:**
ICON plc, a leading global provider of outsourced development and commercialisation services to the pharmaceutical, biotechnology, and medical device industries, is seeking a Senior Director, Group Accounting & Reporting to join our world-class finance team.
In this highly visible role, you will act as a key advisor on ICON’s global accounting and reporting, ensuring compliance with US GAAP and IFRS standards, and providing critical guidance that shapes our financial strategy as a NASDAQ-listed, Irish-headquartered organisation. With over 1,200 professionals a...
Apply for this Job
Submit your application for the Senior Director, Finance position at ICON Clinical Research.
Apply Now Save for LaterJob Overview
Job Type:
Full-time
Location:
Dublin, Ireland
Posted:
March 02, 2026
Deadline:
April 04, 2026